Crescenta Biosciences
Crescenta Biosciences is dedicated to harnessing immunometabolism and small molecule therapy to develop first-in-class drugs aimed at curing age-related diseases and cancer. Their innovative platform focuses on modulating immune responses by targeting lipid binding proteins, advancing transformative drugs through clinical development towards commercialization.
Industries
Nr. of Employees
small (1-50)
Crescenta Biosciences
5270 California Avenue, Suite 300, Irvine, CA 92617
Patents
Products
Discovery Platform
A platform focused on modulating the immune response by targeting lipid binding proteins to develop first-in-class drugs for challenging diseases.
Lead Compound Identification
Process of identifying lead compounds that selectively engage with biological targets and influence their function in cells.
In Vivo Proof-of-Concept
Establishing disease-modifying activity of drug candidates in relevant animal models.
Lead Optimization
Optimizing efficacy, pharmacokinetic, and toxicokinetic parameters of drug candidates.
IND-Enabling Studies
Conducting studies required by regulatory authorities to initiate human clinical trials.
Discovery Platform
A platform focused on modulating the immune response by targeting lipid binding proteins to develop first-in-class drugs for challenging diseases.
Lead Compound Identification
Process of identifying lead compounds that selectively engage with biological targets and influence their function in cells.
In Vivo Proof-of-Concept
Establishing disease-modifying activity of drug candidates in relevant animal models.
Lead Optimization
Optimizing efficacy, pharmacokinetic, and toxicokinetic parameters of drug candidates.
IND-Enabling Studies
Conducting studies required by regulatory authorities to initiate human clinical trials.
Services
Discovery and preclinical development of small-molecule therapeutics that modulate immune function by targeting lipid-binding proteins and related metabolic pathways.
Support for partnership formation, IP licensing, and strategies to advance discovery programs toward commercialization.
Discovery and preclinical development of small-molecule therapeutics that modulate immune function by targeting lipid-binding proteins and related metabolic pathways.
Support for partnership formation, IP licensing, and strategies to advance discovery programs toward commercialization.
Expertise Areas
- Immunometabolism research
- Small-molecule drug discovery
- Medicinal chemistry and lead optimization
- Target identification and validation
Key Technologies
- Immunometabolism modulation
- Small-molecule therapeutics
- Lipid-binding protein targeting
- High-throughput small-molecule screening